Johnson & Johnson has filed a request for arbitration to end its agreement between drug company Schering-Plough Corp. and J&J's Centocor subsidiary because of the pending merger between Schering-Plough and Merck & Co.
Copyright PHILY - Philly.com
Johnson & Johnson has filed a request for arbitration to end its agreement between drug company Schering-Plough Corp. and J&J's Centocor subsidiary because of the pending merger between Schering-Plough and Merck & Co.